A contemporary review of adult heart transplantation: 2012 to 2013

Journal of Heart and Lung Transplantation

Volumn 33, Issue 8, 2014, Pages 775-784

  Depasquale, Eugene C ^a   Schweiger, Martin ^b   Ross, Heather J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

cardiac allograft vasculopathy; donor management; graft allocation; graft preservation; heart transplantation; outcomes; rejection

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CARDIOMYOPATHY; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY FUNCTION; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RETRANSPLANTATION; VASCULAR DISEASE; ADULT; GRAFT REJECTION; PATIENT SELECTION; TRANSPLANTATION; TREATMENT OUTCOME; TRENDS;

IMMUNOSUPPRESSIVE AGENT;

ADULT; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PATIENT SELECTION; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME;

EID: 84905091635     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2014.04.019     Document Type: Article

References (79)

1. M.R. Shah, R.C. Starling, L. Schwartz Longacre, M.R. Mehra, and P. Working Group Heart transplantation research in the next decade - a goal to achieving evidence-based outcomes: National Heart, Lung, And Blood Institute Working Group J Am Coll Cardiol 59 2012 1263 1269
2. C.W. White, A. Ali, and D. Hasanally et al. A cardioprotective preservation strategy employing ex vivo heart perfusion facilitates successful transplant of donor hearts after cardiocirculatory death J Heart Lung Transplant 32 2013 734 743
3. C. Atkinson, B. Floerchinger, and F. Qiao et al. Donor brain death exacerbates complement-dependent ischemia/reperfusion injury in transplanted hearts Circulation 127 2013 1290 1299
4. Y. Yang, H. Lin, and Z. Wen et al. Keeping donor hearts in completely beating status with normothermic blood perfusion for transplants Ann Thorac Surg 95 2013 2028 2034
5. K. Noda, N. Shigemura, and Y. Tanaka et al. A novel method of preserving cardiac grafts using a hydrogen-rich water bath J Heart Lung Transplant 32 2013 241 250
6. A.J. Watson, L. Gao, and L. Sun et al. Enhanced preservation of the rat heart after prolonged hypothermic ischemia with erythropoietin-supplemented Celsior solution J Heart Lung Transplant 32 2013 633 640
7. K.K. Khush, R. Menza, J. Nguyen, J.G. Zaroff, and B.A. Goldstein Donor predictors of allograft use and recipient outcomes after heart transplantation Circ Heart Fail 6 2013 300 309
8. K.W. Southerland, A.W. Castleberry, J.B. Williams, M.A. Daneshmand, A.A. Ali, and C.A. Milano Impact of donor cardiac arrest on heart transplantation Surgery 154 2013 312 319
9. M.A. Quader, L.G. Wolfe, and V. Kasirajan Heart transplantation outcomes from cardiac arrest-resuscitated donors J Heart Lung Transplant 32 2013 1090 1095
10. A. Vorlat, V.M. Conraads, and P.G. Jorens et al. Donor B-type natriuretic peptide predicts early cardiac performance after heart transplantation J Heart Lung Transplant 31 2012 579 584
11. J.M. Smits, M. De Pauw, and E. de Vries et al. Donor scoring system for heart transplantation and the impact on patient survival J Heart Lung Transplant 31 2012 387 397
12. E.S. Weiss, J.G. Allen, and A. Kilic et al. Development of a quantitative donor risk index to predict short-term mortality in orthotopic heart transplantation J Heart Lung Transplant 31 2012 266 273
13. T. Dardas, N.A. Mokadam, F. Pagani, K. Aaronson, and W.C. Levy Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective organ procurement and transplantation network status 1A time J Am Coll Cardiol 60 2012 36 43
14. O. Wever-Pinzon, S.G. Drakos, and A.G. Kfoury et al. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified? Circulation 127 2013 452 462
15. T.P. Singh, C.S. Almond, D.O. Taylor, and D.A. Graham Decline in heart transplant wait list mortality in the United States following broader regional sharing of donor hearts Circ Heart Fail 5 2012 249 258
16. T.P. Singh, C.S. Almond, D.O. Taylor, C.E. Milliren, and D.A. Graham Racial and ethnic differences in wait-list outcomes in patients listed for heart transplantation in the United States Circulation 125 2012 3022 3030
17. I. Kaczmarek, M.M. Zaruba, and A. Beiras-Fernandez et al. Tacrolimus with mycophenolate mofetil or sirolimus compared with calcineurin inhibitor-free immunosuppression (sirolimus/mycophenolate mofetil) after heart transplantation: 5-year results J Heart Lung Transplant 32 2013 277 284
18. P. Boissonnat, S. Gaillard, and C. Mercier et al. Impact of the early reduction of cyclosporine on renal function in heart transplant patients: a French randomised controlled trial Trials 13 2012 231
19. S. Guethoff, B.M. Meiser, and J. Groetzner et al. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation Transplantation 95 2013 629 634
20. A. Zuckermann, S.S. Wang, and E. Epailly et al. Everolimus immunosuppression in de novo heart transplant recipients: what does the evidence tell us now? Transplant Rev (Orlando) 27 2013 76 84
21. H.J. Eisen, J. Kobashigawa, and R.C. Starling et al. Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial Am J Transplant 13 2013 1203 1216
22. J. Kobashigawa, H. Ross, and C. Bara et al. Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation Transpl Infect Dis 15 2013 150 162
23. L.H. Lund, L.B. Edwards, and A.Y. Kucheryavaya et al. The Registry of the International Society for Heart and Lung Transplantation: thirtieth official adult heart transplant report - 2013; focus theme: age J Heart Lung Transplant 32 2013 951 964
24. F. Gonzalez-Vilchez, J.A. Vazquez de Prada, and L. Almenar et al. Withdrawal of proliferation signal inhibitors due to adverse events in the maintenance phase of heart transplantation J Heart Lung Transplant 31 2012 288 295
25. M.S. Lee, R.K. Cheng, D.E. Kandzari, and A.J. Kirtane Long-term outcomes of heart transplantation recipients with transplant coronary artery disease who develop in-stent restenosis after percutaneous coronary intervention Am J Cardiol 109 2012 1729 1732
26. J.A. Kobashigawa, D.F. Pauly, and R.C. Starling et al. Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients JACC Heart Fail 1 2013 389 399
27. Y. Topilsky, T. Hasin, and E. Raichlin et al. Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation Circulation 125 2012 708 720
28. Y. Matsuo, A. Cassar, and S. Yoshino et al. Attenuation of cardiac allograft vasculopathy by sirolimus: relationship to time interval after heart transplantation J Heart Lung Transplant 32 2013 784 791
29. M. Masetti, L. Potena, and M. Nardozza et al. Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice Am J Transplant 13 2013 1217 1226
30. O. Prada-Delgado, R. Estevez-Loureiro, M.J. Paniagua-Martin, A. Lopez-Sainz, and M.G. Crespo-Leiro Prevalence and prognostic value of cardiac allograft vasculopathy 1 year after heart transplantation according to the ISHLT recommended nomenclature J Heart Lung Transplant 31 2012 332 333
31. M.R. Mehra, M.G. Crespo-Leiro, and A. Dipchand et al. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010 J Heart Lung Transplant 29 2010 717 727
32. J. Hou, H. Lv, and H. Jia et al. OCT assessment of allograft vasculopathy in heart transplant recipients JACC Cardiovasc Imag 5 2012 662 663
33. A. Pollack, T. Nazif, D. Mancini, and G. Weisz Detection and imaging of cardiac allograft vasculopathy JACC Cardiovasc Imag 6 2013 613 623
34. C. Wenning, J. Stypmann, and P. Papavassilis et al. Left ventricular dilation and functional impairment assessed by gated SPECT are indicators of cardiac allograft vasculopathy in heart transplant recipients J Heart Lung Transplant 31 2012 719 728
35. O. Barthelemy, D. Toledano, and S. Varnous et al. Multislice computed tomography to rule out coronary allograft vasculopathy in heart transplant patients J Heart Lung Transplant 31 2012 1262 1268
36. I.P. Garrido, J. Garcia-Lara, and E. Pinar et al. Optical coherence tomography and highly sensitivity troponin T for evaluating cardiac allograft vasculopathy Am J Cardiol 110 2012 655 661
37. D. Lin, G. Cohen Freue, and Z. Hollander et al. Plasma protein biosignatures for detection of cardiac allograft vasculopathy J Heart Lung Transplant 32 2013 723 733
38. N. Singh, E. Van Craeyveld, and M. Tjwa et al. Circulating apoptotic endothelial cells and apoptotic endothelial microparticles independently predict the presence of cardiac allograft vasculopathy J Am Coll Cardiol 60 2012 324 331
39. K.P. Daly, M.E. Seifert, and A. Chandraker et al. VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients J Heart Lung Transplant 32 2013 120 128
40. J.R. Braga, I.S. Santos, M. McDonald, P.S. Shah, and H.J. Ross Factors associated with the development of cardiac allograft vasculopathy - a systematic review of observational studies Clin Transplant 26 2012 E111 E124
41. J.J. Devitt, A. Rice, D. McLean, S.K. Murray, G.M. Hirsch, and T.D. Lee Impact of donor benign intimal thickening on cardiac allograft vasculopathy J Heart Lung Transplant 32 2013 454 460
42. M.P. Pantou, A. Manginas, P.A. Alivizatos, and D. Degiannis Connective tissue growth factor (CTGF/CCN2): a protagonist in cardiac allograft vasculopathy development? J Heart Lung Transplant 31 2012 881 887
43. Y. Topilsky, M.J. Gandhi, and T. Hasin et al. Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study Transplantation 95 2013 389 396
44. R. Frank, M.R. Molina, J.W. Wald, L.R. Goldberg, M. Kamoun, and P. Lal Correlation of circulating donor-specific anti-HLA antibodies and presence of C4d in endomyocardial biopsy with heart allograft outcomes: a single-center, retrospective study J Heart Lung Transplant 32 2013 410 417
45. Y. Topilsky, E. Raichlin, and T. Hasin et al. Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantation Transplantation 95 2013 859 865
46. A. Kilic, E.S. Weiss, and J.G. Allen et al. Simple score to assess the risk of rejection after orthotopic heart transplantation Circulation 125 2012 3013 3021
47. C.M. Orrego, A.M. Cordero-Reyes, J.D. Estep, M. Loebe, and G. Torre-Amione Usefulness of routine surveillance endomyocardial biopsy 6 months after heart transplantation J Heart Lung Transplant 31 2012 845 849
48. C.A. Miller, J.E. Fildes, and S.G. Ray et al. Non-invasive approaches for the diagnosis of acute cardiac allograft rejection Heart 99 2013 445 453
49. I. Sukma Dewi, K. Torngren, O. Gidlof, B. Kornhall, and J. Ohman Altered serum miRNA profiles during acute rejection after heart transplantation: potential for non-invasive allograft surveillance J Heart Lung Transplant 32 2013 463 466
50. M. Tible, A. Loupy, and D. Vernerey et al. Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation J Heart Lung Transplant 32 2013 769 776
51. M. Fedrigo, G. Feltrin, and F. Poli et al. Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection J Heart Lung Transplant 32 2013 404 409
52. A.G. Kfoury, G.L. Snow, and D. Budge et al. A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation J Heart Lung Transplant 31 2012 46 51
53. H.L. Thomas, N.R. Banner, and C.L. Murphy et al. Incidence, determinants, and outcome of chronic kidney disease after adult heart transplantation in the United Kingdom Transplantation 93 2012 1151 1157
54. S.P. Pinney, R. Balakrishnan, and S. Dikman et al. Histopathology of renal failure after heart transplantation: a diverse spectrum J Heart Lung Transplant 31 2012 233 237
55. S. Arora, E. Gude, and V. Sigurdardottir et al. Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate J Heart Lung Transplant 31 2012 259 265
56. L. Potena, P. Prestinenzi, and I.G. Bianchi et al. Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective study J Heart Lung Transplant 31 2012 565 570
57. A. Zuckermann, A. Keogh, and M.G. Crespo-Leiro et al. Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency Am J Transplant 12 2012 2487 2497
58. R.J. Tedford, C. James, and D.P. Judge et al. Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy J Am Coll Cardiol 59 2012 289 290
59. T.S. Kato, H. Takayama, and S. Yoshizawa et al. Cardiac transplantation in patients with hypertrophic cardiomyopathy Am J Cardiol 110 2012 568 574
60. E.C. DePasquale, K. Nasir, and D.L. Jacoby Outcomes of adults with restrictive cardiomyopathy after heart transplantation J Heart Lung Transplant 31 2012 1269 1275
61. J.K. Bhama, J. Shulman, and C.A. Bermudez et al. Heart transplantation for adults with congenital heart disease: results in the modern era J Heart Lung Transplant 2013 32499 32504
62. S. Kanai-Yoshizawa, T. Sugiyama Kato, D. Mancini, and C.C. Marboe Hypersensitivity myocarditis and outcome after heart transplantation J Heart Lung Transplant 32 2013 553 559
63. S. Yoshizawa, T.S. Kato, D. Mancini, and C.C. Marboe Outcome of patients having heart transplantation for lymphocytic myocarditis Am J Cardiol 112 2013 405 410
64. M.S. Khan, C.M. Mery, and F. Zafar et al. Is mechanically bridging patients with a failing cardiac graft to retransplantation an effective therapy? Analysis of the United Network of Organ Sharing database J Heart Lung Transplant 31 2012 1192 1198
65. K. Rasmusson, K. Brunisholz, and D. Budge et al. Peripartum cardiomyopathy: post-transplant outcomes from the United Network for Organ Sharing Database J Heart Lung Transplant 31 2012 180 186
66. D.J. Goldstein, R. Bello, and J.J. Shin et al. Outcomes of cardiac transplantation in septuagenarians J Heart Lung Transplant 31 2012 679 685
67. A. Kilic, E.S. Weiss, and G.J. Arnaoutakis et al. Identifying recipients at high risk for graft failure after heart retransplantation Ann Thorac Surg 93 2012 712 716
68. A. Kilic, E.S. Weiss, and T.J. George et al. What predicts long-term survival after heart transplantation? An analysis of 9,400 ten-year survivors Ann Thorac Surg 93 2012 699 704
69. J.G. Allen, E.S. Weiss, and G.J. Arnaoutakis et al. Insurance and education predict long-term survival after orthotopic heart transplantation in the United States J Heart Lung Transplant 31 2012 52 60
70. S.A. Farmer, K.L. Grady, E. Wang, E.C. McGee Jr, W.G. Cotts, and P.M. McCarthy Demographic, psychosocial, and behavioral factors associated with survival after heart transplantation Ann Thorac Surg 95 2013 876 883
71. A. Chokshi, F.H. Cheema, and K.J. Schaefle et al. Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction J Heart Lung Transplant 31 2012 591 600
72. J.A. Yang, T.S. Kato, and B.P. Shulman et al. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system J Heart Lung Transplant 31 2012 601 610
73. A. Kilic, J.V. Conte, A.S. Shah, and D.D. Yuh Orthotopic heart transplantation in patients with metabolic risk factors Ann Thorac Surg 93 2012 718 724
74. V. Sigurdardottir, O. Bjortuft, and H. Eiskjaer et al. Long-term follow-up of lung and heart transplant recipients with pre-transplant malignancies J Heart Lung Transplant 31 2012 1276 1280
75. G.M. Frohlich, K. Rufibach, and F. Enseleit et al. Statins and the risk of cancer after heart transplantation Circulation 126 2012 440 447
76. G. Tydén, I. Hagerman, and K.H. Grinnemo et al. Intentional ABO-incompatible heart transplantation: a case report of 2 adult patients J Heart Lung Transplant 31 2012 1307 1310
77. S.J. Pettit, P.S. Jhund, and N.M. Hawkins et al. How small is too small? A systematic review of center volume and outcome after cardiac transplantation Circ Cardiovasc Qual Outcomes 5 2012 783 790
78. G.J. Arnaoutakis, T.J. George, and J.G. Allen et al. Institutional volume and the effect of recipient risk on short-term mortality after orthotopic heart transplant J Thorac Cardiovasc Surg 143 2012 157 167 (67e1)
79. A. Kilic, E.S. Weiss, and D.D. Yuh et al. Institutional factors beyond procedural volume significantly impact center variability in outcomes after orthotopic heart transplantation Ann Surg 256 2012 616 623